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There are large variations in the reported efficiency of gold nanoparticle (GNP) radiosensitization. 
We have previously reported on a predictive model, which accounts for the detailed Auger and 
photoelectron tracks to calculate the cell survival probability. After validating our model using PC-3 cells 
incubated with 2 mg/ml of 30 nm GNPs and irradiated with 100 kVp or 300 kVp beams, we evaluated the 
interplay between photon energy, GNP size (1.9 and 100 nm) and sub-cellular localization. Experiments 
were in excellent agreement with the model. In predictive modeling, using a 100 kVp source and 1.9 nm 
nanoparticles, GNP localization had a significant impact on cell survival. A sensitizer enhancement ratio 
of 1.34 was achieved when GNPs were localized outside the cells, increasing to 2.56 when GNPs were 
also distributed in the cytoplasm and nucleus. Using a 300 kVp source, which emits photons mainly 
above the gold K-edge, the dependence on GNP localization and size was barely detectable, since long 
ranged electrons dominate the energy deposition. In summary, achieving intracellular uptake with 
targeted-GNPs can significantly enhance radiosensitization for photon energies below the gold K-edge, 
where Auger electrons contribute significantly to the local energy deposition. For higher energies, this is 
much less important.
Gold nanoparticles (GNPs) have been proposed to physically enhance radiation therapy1–7. The mechanism of 
radiosensitization involves three different steps: i/- the selective accumulation of GNPs in the tumor at close 
proximity to the cancer cell nucleus target; ii/- an increased photoelectric absorption of low-energy photons 
within gold atoms at the tumor site; iii/- the release of low-energy Auger and photoelectrons from GNPs, and 
the interaction of these secondary electrons with sensitive cellular targets8. GNP radiosensitization introduces a 
major modification to the pattern of energy deposition, leading to a more heterogeneous microscopic dose dis-
tribution, and resulting in electrons with very short ranges, increased linear energy transfer (LET), and a larger 
relative biological effectiveness (RBE).
The efficacy of GNP radiosensitization has been demonstrated in vitro in DNA plasmids and cell models1–5, 
and in vivo in mice model6,7. There is however very large variation in the reported RBE, which may be related to 
physical and pharmacological parameters including the primary photon energy spectrum, the GNP size, and the 
achievable tumor concentration and the sub-cellular localization1–3. The absorbed dose, which is the traditional 
metric correlated to a clinical effect, cannot adequately predict the effect of GNP radiosensitization on cell sur-
vival9–13. Our team has developed a radiobiological model called the gold (Au) nanoparticle radiosensitization 
predictive model (ARP). The ARP model was adapted from Kraft’s local effect model (LEM), which was designed 
to predict the increased RBE of heavy ion therapy11–15.
In the ARP model, photoelectric absorptions within GNPs are simulated, and detailed 3D nanoscale radia-
tion transport and energy deposition of secondary radiation inside the cell nucleus are produced using Monte 
Carlo simulations12. Those elementary tracks are used to calculate the fractional probability of cell killing in 
20 × 20 × 20 nm3 voxels of the cell nucleus using standard linear-quadratic radiosensitivity parameters. Finally, 
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it calculates the cell survival probability by summing the fractional cell killing probabilities. This model incorpo-
rates information of the cancer cell geometry and intrinsic radiosensitivity, as well as the photon source spectrum, 
GNP size, concentration, and intracellular localization. In this article, after validating the ARP model with exper-
imental clonogenic assays using various photons energies, we analyzed the subtle interplay between the photon 
source energy, GNP size and sub-cellular localization.
Methods
Experimental data validating the ARP model. In vitro experiments were carried out using the PC-3 
human prostate adenocarcinoma cell line (American Type Culture Collection, Manassas, VA). Cells were main-
tained in RPMI 1640 with L-glutamine and sodium bicarbonate supplemented with 10% fetal bovine serum 
(Cellgro laboratories, Manassas, VA) and 5% penicillin with streptomycin (Invitrogen, Carlsbad, CA). Prior to 
experimentation, exponentially growing cells were seeded in 35 mm culture plates and grown to 80% confluence.
GNP colloids of 30 nm in diameter (Ted Pella Inc., Redding, CA) were PEGylated to prevent aggregation and 
then concentrated through centrifugation. Highly concentrated GNPs were re-suspended in cell culture media 
at gold concentrations of 2 mg/ml. Cell cultures were incubated with this mixture for 24 hours, then thoroughly 
washed with PBS to remove any nanoparticles not taken up in cells prior to irradiation and analysis. GNP cellu-
lar uptake was quantified using inductively coupled plasma mass spectroscopy (ICPMS) and GNP intracellular 
localization was visualized using transmission electron microscopy (TEM).
Irradiations were carried out on a clinical Gulmay D3300 (Chertsey, UK) x-ray therapy unit at energies of 300 
kVp and 100 kVp using a 10 cm diameter cone collimator. Radiation was delivered from above the culture dishes 
penetrating 4 mm of cell culture media. Cultures of PC-3 cells with or without gold in the media for 24 hours were 
irradiated at 0, 1, 2, 4, or 8 Gy. Average cell survival was assessed using the clonogenic assay and normalized rela-
tive to the plating efficiency of controls receiving no radiation with and without GNPs. This was done to control 
for possible cytotoxic effects of GNPs. Survival as a function of dose for irradiations without GNPs was fit to the 
linear-quadratic cell survival model = α β− +S e D D( )
2
, with the α and β parameters extracted using non-linear 
least-squares regression analysis in Matlab (MATLAB 7.14, The MathWorks Inc., Natick, MA, 2012).
Monte Carlo simulation of GNP radiosensitization. The ARP model starts with the simulation of the 
3D nanoscale energy deposition of photoelectric products escaping individual GNPs. To model this phenomenon 
while balancing computation efficiency, Monte Carlo simulations were performed using two different Monte 
Carlo Codes - MCNP-5 (Los Alamos National Laboratory) and PENELOPE 2008.1 (Barcelona, Catalonia)16,17. 
MCNP-5 includes powerful variance reduction tools and was used to generate the 100 kVp and 300 kVp photons 
phase space, as well as to calculate the rate of photoelectric absorption in GNPs after transport through 4 mm 
of cell culture media12. PENELOPE was used to simulate the interaction of photons with GNPs of 1.9, 30, and 
100 nm diameters. PENELOPE was chosen due to the flexibility of its geometry package and customizable tal-
lies. Furthermore, it offers detailed event-by-event electron transport through various mediums including tissue 
and gold down to 50 eV corresponding to electron ranges of about 2–4 nm. The individual tracks and nanoscale 
energy deposition of escaping electrons and photons were recorded using a customized tally12.
The ARP model. The ARP model included a simplified three-compartment spherical cell model with a cyto-
plasm region, a radiosensitive nucleus region, and an extracellular region. PC-3 nucleus and cytoplasm dimen-
sions were taken from previous studies12,18. GNP concentrations and distributions within these compartments 
were based on experimental data for model validation. They were then varied for the hypothetical cases testing 
the effect of GNP size, sub-cellular distribution and photon energy spectrum. Randomly selected secondary radi-
ation tracks from a library of photons interactions within GNPs were applied to random locations within the 
sub-cellular compartments of a PC-3, and the energy deposition was scored within a matrix of 20 × 20 × 20 nm3 
nucleus voxels. The background dose delivered by photons was then homogeneously distributed throughout the 
nucleus (see Supplementary Figure S1 for a schematic diagram of the ARP model).
Cell survival was determined by integrating the local dose response, or lethal event density, in each voxel over 
the nucleus volume as follow:
∫= −S e (1)v D dV( )local
The lethal event density was defined by a two component formulation based on the linear-quadratic cell sur-
vival model for local doses below a threshold value, Dt, and a purely exponential survival model for local doses 
































Where α and β represent the cell radiosensitivity parameters of the linear-quadratic model for low-LET photon 
radiation without GNPs present, Dlocal is the sum of the dose deposited from GNPs and the background radiation, 
and α β= +S D2max t. The threshold dose for PC-3 cells has been previously empirically determined for the ARP 
model to be 23.9 Gy12.
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Metrics of comparison. For the validation of the ARP model, the mean inactivation dose (MID) was used 
as metric of comparison between experimental and theoretical data. The MID corresponds to the area under the 
cell survival curves. Sensitizer enhancement ratios (SER) were calculated by dividing the MID without GNPs by 
the MID with GNPs1.
Data availability. The authors will make materials, data and associated protocols promptly available to read-
ers upon request.
Results
Table 1 presents the cellular dimensions obtained from previous publications, and summarizes the ICPMS results 
quantifying GNP cellular uptake concentrations. Because GNPs were not found in the nucleus on TEM imaging, 
the estimated concentration of gold in the cells was expressed per ml of cytoplasmic volume.
Figure 1 shows PC-3 experimental cell survival as a function of dose with and without 30 nm GNPs incubated 
at 2 mg/ml using the 100 kVp and the 300 kVp photon sources. There is a strong agreement with the ARP model 
predictions. Without GNPs, experimental PC-3 cell survival as a function of dose did not differ significantly 
between the 100 kVp and 300 kVp source, so the PC-3 cell sensitivity parameters were kept constant for both 
energies at α = 0.217 and β = 0.044 for the ARP survival model.
Using the 100 kVp photon source, Monte Carlo simulations estimated the rate of photoelectric absorption in a 
single 30 nm GNP to be 9.05 × 10−3 absorptions per 1 Gy delivered to the media. For a 300 kVp source the photo-
electric absorption rate was estimated to be about 9 times less at 1.00 × 10−3 absorptions per 1 Gy.
Figure 2 shows predictive survival curves using either 100 or 300 kVp sources, varying sub-cellular distri-
butions at a realistic concentration of 2 mg/ml, and for 1.9 nm or 100 nm GNPs. Three GNP localizations were 
considered for each case: 1) GNPs localized in the media only, 2) GNPs localized in the media and cell cytoplasm 
at the same concentration, 3) GNPs localized in the media, cytoplasm and nucleus. The effect of GNP localization 
was observed to be much more pronounced in the case of the 100 kVp source along with 1.9 nm GNPs. For this 
case, a SER of 1.34 was predicted when GNPs were localized outside the cells, increasing to 2.56 when GNPs were 
also distributed in the cytoplasm and nucleus. For the 300 kVp source, the dependence on GNP localization and 
size was barely detectable with a SER averaging about 1.2 for all cases. Varying the GNP size had a large influence 
on the cell survival when using the lower energy source and when nanoparticles were located in the cell nucleus. 
It had little or no influence for higher energy of when the GNP was in the cytoplasm or the media.
Cytoplasm radius ± SD (μm) 13.1 ± 2.5
Nucleus radius ± SD (μm) 8.2 ± 2.1
GNP size (nm) 30
GNP concentration in media (mg/ml) 2
GNPs per cell ± SD 2.27 × 104 ± 1.47 × 104
GNP concentration in cytoplasm (mg/ml) 0.84
Table 1. Experimental PC-3 cell dimensions and GNP cellular uptake.
Figure 1. The ARP model shows close agreement with experimental cell survival for PC-3 cells incubated with 
2 mg/ml of GNPs and irradiated using 100 kVp or 300 kVp photon energies. Cell survival with no GNPs was fit 
to the linear quadratic model (LQ) and depicted as well.
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Discussion
The ARP model was developed to account for the increased biological efficiency of short-ranged, high LET Auger 
electrons compared to long-ranged, low LET photoelectrons12. Similar to the LEM model, the ARP model exploits 
the unique and heterogeneous sub-cellular intra-nuclear energy deposition of high LET radiation14,15. The experi-
mental cell survival values for 100 kVp and 300 kVp are in excellent agreement with the survival curves predicted 
by the ARP model for prostate PC-3 cancer cells. The two beam energies were specifically chosen because they 
yield photons with average energies of ≈33 keV and 100 keV respectively, meaning above or below the k-edge of 
gold (80.7 keV). Since the agreement is excellent, we assume that our simulations varying the sub-cellular locali-
zation or the size of the nanoparticles are reliable.
We hypothesized that cell survival would be highly dependent on the interplay between beam energy, and the 
size and localization of GNPs, and this is illustrated in Fig. 2. For the 300 kVp source, with a mean energy above 
the k-edge of gold, most of the primary photon energy is deposited by the longer-ranged photoelectrons, which 
do not have a significantly increased LET12. With this beam energy, the cell survival was not heavily influenced by 
GNP size or sub-cellular localization because the photoelectric products easily escape the nanoparticle and travel 
multiple cell lengths. At this energy, a modest SER of about 1.2 was observed, which may have a limited clinical 
significance.
On the other hand, using the 100 kVp source, with a mean energy below the gold k-edge, the energy is depos-
ited more locally in the media by shorter-ranged electrons including high-LET Auger electrons, with maximum 
ranges of 1.5 μm, 0.1 μm, and 0.01 μm for transitions from the gold atom L, M, and N shells respectively12. Using 
the lower energy source, we found the cell survival to be highly dependent on the GNP size and localization. 
When GNPs were located too far from the nucleus, the short-range Auger electrons could not reach the DNA 
target. Furthermore, when GNPs were too large, the Auger electrons got trapped inside the large nanoparticle. 
Figure 2. The predicted effects of varying GNP cellular and nuclear accumulation. When GNPs were simulated 
in a region, the concentration was set to 2 mg/ml. (a) ARP predictions using a 100 kVp source and 1.9 nm GNPs. 
(b) ARP predictions using a 100 kVp source and 100 nm GNPs. (c) ARP predictions using a 300 kVp source and 
1.9 nm GNPs. (d) ARP predictions using a 300 kVp source and 100 nm GNPs.
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In our simulations, the SER was maximized when using a low-energy source, along with small, nucleus-localized 
nanoparticles.
There have been several reports suggesting that besides the Auger cascade, other mechanisms could be at 
play to explain GNP radiosensitization18–21. However, if the goal is to maximize the Auger electrons production, 
the results presented in this article are central to designing a clinical strategy. If the intent is to use low-energy 
sources, such as miniature electronic x-ray or brachytherapy sources such as 125I or 103Pd, the radiosensitization 
could be dramatically enhanced by actively accumulating GNPs into the cell cytoplasm through conjugation with 
tumor targeting moieties22,23. Further enhancement could possibly be achieved through conjugation with nuclear 
localizing sequences24,25, but this would require GNPs small enough to pass through the ~5 nm nuclear pore com-
plex, meaning that possibly much lower total gold concentrations would be achieved26. If the clinical application 
involves higher-energy sources, such as 192Ir used in high-dose-rate brachytherapy or external beam x-rays, the 
radiosensitization will mostly be linked to longer-ranged photoelectrons. In this case, GNP localization is less 
crucial and therefore a passive approach to GNP administration could be employed. GNPs would need to be 
loaded into tumors at relatively high concentrations of about 2 mg/ml, which could be achieved through direct 
intra-tumoral injection27.
The present modelization results suggest that for photon energies below the k-edge, the bulk gold concen-
tration is not a good predictor for radiosensitization, and that knowledge of the intracellular concentration and 
localization is crucial. With this insight, the ARP model could explain some apparently contradictory reports of 
GNP radiosensitization. For example, Chithrani reported results of GNP radiosensitization using HeLa cells incu-
bated with 50 nm GNPs at a media concentration of 0.0088 mg/ml28. Using a 105 kVp photon source, Chithrani 
observed cell survival comparable to our experimental results, despite the fact the incubated GNP concentration 
was 227 times lower than our study. This discrepancy could be explained by the fact that in both experiments 
similar intracellular gold concentrations were observed, between 6.3 μg and 7.6 μg, while the concentration in the 
media was indeed different. As we have shown for 100 kVp energies, the ARP model predicts that intracellular 
GNP concentration is a critical parameter.
One limitation of this work is that we used a highly simplified spherical cell geometry and assumed a uniform 
distribution of gold in sub-cellular compartments. This model functioned well to mimic the in vitro experiments, 
but the in vivo cellular and gross tumor morphology could be drastically different. GNPs can cluster into phago-
lysosomes and will be taken up at different concentrations by individual cancer cells28. The cell geometry evolves 
throughout the cell cycle, and can take on a spindle shape, with a more compact nucleus polarized to one side 
of the cell, closer to the extra-cellular space. Therefore, the DNA is a moving target, which could move closer or 
out of reach of the low-energy Auger electron spray arising from a nanoparticle29. Additional work is needed to 
evaluate the ARP model in realistic in vivo cellular geometry and with heterogeneous GNP distributions.
In this study, we utilized the ARP model to explore GNP radiosensitization with PC-3 prostate cancer cells 
and two clinical energies. However, the ARP model was designed as a general model that can be applied to various 
clinical scenarios, meaning using different beam energies and various cell radiosensitivity. We have theoretical 
results using 125I (average energy 28 keV) and 192Ir (average energy 395 keV) sources, which demonstrate the same 
trend of increasing SER with lower-energy sources, along with a stronger dependence on GNP localization. We 
have also conducted experiments with the SKBR-3 breast cancer cell line, with hence different α and β cell radio-
sensitivity values, and have obtained likewise excellent agreement with ARP model predictions.
To apply the ARP model to different biological conditions, experimental linear-quadratic α and β sensitivity 
parameters are required to accurately predict cell survival. This also opens the possibility to evaluate, at least in 
theory, additional clinical strategies that modify cell radiosensitivity. For example, the ARP model could pro-
vide insight into combining GNP radiosensitization with modifiers of the DNA repair pathway including lap-
atinib, hyperthermia which act through the inhibition of the BRCA homologous recombination DNA repair 
pathway30,31, or other specific clinical situations including hypoxia. On the other hand of the spectrum, this model 
could be use to evaluate strategies using Auger cascades radiosensitization32.
In summary, there is a significant interplay between GNP localization and size using low-energy sources 
below the k-edge. At those energies, the biological effect can be more than double. For higher energies, the GNP 
localization and size are much less important since the photo-electrons dominate the energy deposition.
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